The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: Zeneca Pharmaceuticals
Approval Status: Approved September 1997
Treatment for: psychotic disorders
General Information
The U.S. Food and Drug Administration approved Zeneca's Seroquel (R) (quetiapine fumarate) tablets, an oral medication indicated for the management of the manifestations of psychotic disorders, including schizophrenia. Seroquel was shown to be effective in treating both the positive symptoms (i.e., hallucinations, delusions) and negative symptoms (i.e., emotional withdrawal, blunted affect) associated with schizophrenia.